Literature DB >> 21937696

An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets.

Shaista Nisar1, Martina E Daly, Augusto B Federici, Andrea Artoni, Andrew D Mumford, Stephen P Watson, Stuart J Mundell.   

Abstract

The platelet P2Y(12) purinoceptor (P2Y(12)R), which plays a crucial role in hemostasis, undergoes internalization and subsequent recycling to maintain receptor responsiveness, processes that are essential for normal platelet function. Here, we observe that P2Y(12)R function is compromised after deletion or mutation of the 4 amino acids at the extreme C-terminus of this receptor (ETPM), a putative postsynaptic density 95/disc large/zonula occludens-1 (PDZ)-binding motif. In cell line models, removal of this sequence or mutation of one of its core residues (P341A), attenuates receptor internalization and receptor recycling back to the membrane, thereby blocking receptor resensitization. The physiologic significance of these findings in the regulation of platelet function is shown by identification of a patient with a heterozygous mutation in the PDZ binding sequence of their P2Y(12)R (P341A) that is associated with reduced expression of the P2Y(12)R on the cell surface. Importantly, platelets from this subject showed significantly compromised P2Y(12)R recycling, emphasizing the importance of the extreme C-terminus of this receptor to ensure correct receptor traffic.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937696      PMCID: PMC3217363          DOI: 10.1182/blood-2011-02-336826

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms.

Authors:  Adam R Hardy; Pamela B Conley; Jiansong Luo; Jeffrey L Benovic; Alastair W Poole; Stuart J Mundell
Journal:  Blood       Date:  2005-01-21       Impact factor: 22.113

Review 2.  P2 receptors, platelet function and pharmacological implications.

Authors:  Christian Gachet
Journal:  Thromb Haemost       Date:  2008-03       Impact factor: 5.249

3.  Subtype-specific intracellular trafficking of alpha2-adrenergic receptors.

Authors:  D A Daunt; C Hurt; L Hein; J Kallio; F Feng; B K Kobilka
Journal:  Mol Pharmacol       Date:  1997-05       Impact factor: 4.436

Review 4.  Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis.

Authors:  Breann L Wolfe; JoAnn Trejo
Journal:  Traffic       Date:  2007-03-21       Impact factor: 6.215

5.  A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor.

Authors:  T T Cao; H W Deacon; D Reczek; A Bretscher; M von Zastrow
Journal:  Nature       Date:  1999-09-16       Impact factor: 49.962

6.  Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).

Authors:  Anne Goodeve; Jeroen Eikenboom; Giancarlo Castaman; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Reinhard Schneppenheim; Ulrich Budde; Jorgen Ingerslev; David Habart; Zdena Vorlova; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Mohammad Hashemi Soteh; Luciano Baronciani; Christer Hallden; Andrea Guilliatt; Will Lester; Ian Peake
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

7.  Rapid resensitization of purinergic receptor function in human platelets.

Authors:  S J Mundell; J F Barton; M B Mayo-Martin; A R Hardy; A W Poole
Journal:  J Thromb Haemost       Date:  2008-05-28       Impact factor: 5.824

Review 8.  G-protein-coupled receptors as signaling targets for antiplatelet therapy.

Authors:  Susan S Smyth; Donna S Woulfe; Jeffrey I Weitz; Christian Gachet; Pamela B Conley; Shaun G Goodman; Matthew T Roe; Athan Kuliopulos; David J Moliterno; Patricia A French; Steven R Steinhubl; Richard C Becker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11-20       Impact factor: 8.311

9.  Type I PDZ ligands are sufficient to promote rapid recycling of G Protein-coupled receptors independent of binding to N-ethylmaleimide-sensitive factor.

Authors:  Robert M Gage; Elena A Matveeva; Sidney W Whiteheart; Mark von Zastrow
Journal:  J Biol Chem       Date:  2004-11-17       Impact factor: 5.157

10.  Induction of mutant dynamin specifically blocks endocytic coated vesicle formation.

Authors:  H Damke; T Baba; D E Warnock; S L Schmid
Journal:  J Cell Biol       Date:  1994-11       Impact factor: 10.539

View more
  17 in total

Review 1.  P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells.

Authors:  Christian Gachet
Journal:  Purinergic Signal       Date:  2012-04-11       Impact factor: 3.765

2.  ASK1 facilitates tumor metastasis through phosphorylation of an ADP receptor P2Y12 in platelets.

Authors:  Miki Kamiyama; Toshiaki Shirai; Shogo Tamura; Katsue Suzuki-Inoue; Shogo Ehata; Kei Takahashi; Kohei Miyazono; Yoshihiro Hayakawa; Takehiro Sato; Kohsuke Takeda; Isao Naguro; Hidenori Ichijo
Journal:  Cell Death Differ       Date:  2017-07-28       Impact factor: 15.828

3.  Arrestin scaffolds NHERF1 to the P2Y12 receptor to regulate receptor internalization.

Authors:  Shaista P Nisar; Margaret Cunningham; Kunal Saxena; Robert J Pope; Eamonn Kelly; Stuart J Mundell
Journal:  J Biol Chem       Date:  2012-05-18       Impact factor: 5.157

4.  The platelet P2Y(12) receptor under normal and pathological conditions. Assessment with the radiolabeled selective antagonist [(3)H]PSB-0413.

Authors:  Philippe Ohlmann; Anna Lecchi; Ali El-Tayeb; Christa E Müller; Marco Cattaneo; Christian Gachet
Journal:  Purinergic Signal       Date:  2012-08-15       Impact factor: 3.765

5.  Identification of a new dysfunctional platelet P2Y12 receptor variant associated with bleeding diathesis.

Authors:  Anna Lecchi; Cristina Razzari; Silvia Paoletta; Arnaud Dupuis; Lea Nakamura; Philippe Ohlmann; Christian Gachet; Kenneth A Jacobson; Barbara Zieger; Marco Cattaneo
Journal:  Blood       Date:  2014-11-26       Impact factor: 22.113

6.  Coupling of P2Y receptors to G proteins and other signaling pathways.

Authors:  Laurie Erb; Gary A Weisman
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012 Nov-Dec

7.  Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel.

Authors:  Ban B Dawood; Gillian C Lowe; Marie Lordkipanidzé; Danai Bem; Martina E Daly; Mike Makris; Andrew Mumford; Jonathan T Wilde; Steve P Watson
Journal:  Blood       Date:  2012-09-21       Impact factor: 22.113

Review 8.  The Function and Regulation of Platelet P2Y12 Receptor.

Authors:  Xiaohua Li; Guoxing Zhang; Xia Cao
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-28       Impact factor: 3.727

Review 9.  Rare platelet GPCR variants: what can we learn?

Authors:  S P Nisar; M L Jones; M R Cunningham; A D Mumford; S J Mundell
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

10.  Use of next-generation sequencing and candidate gene analysis to identify underlying defects in patients with inherited platelet function disorders.

Authors:  V C Leo; N V Morgan; D Bem; M L Jones; G C Lowe; M Lordkipanidzé; S Drake; M A Simpson; P Gissen; A Mumford; S P Watson; M E Daly
Journal:  J Thromb Haemost       Date:  2015-01-27       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.